Patent · US Active

Polymorph of a pharmaceutical

US8193367B2 · kind B2 · utility

2Cited by
12References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 22, 2009
Grant dateJun 5, 2012
Priority date—
Expiry dateJun 16, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D277/28
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

A new crystalline polymorph of ritonavir and methods for its use and preparation are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.